Yoda Pharmaceuticals Inc.

NT$48.70As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7829Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (48.22%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM —
TSR TTM (18.01%)
Mkt cap NT$4.840B
ROIC (31.72%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$54
11.33%
64.31%
Hold 8|7|11|2|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.54
0.54
0.60
0.65
23.71%
13.10%
18.18%
20.61%
RevenueNT$M
501.9
501.9
521.8
551.5
7.56%
5.62%
8.51%
11.38%
Peers (US$146.2M)
Cap (US$)
PE
146.0M
19.01x
Capital
TTM
5Y
10Y
Leveragex
1.969
0.132
0.125
EBIT/Intx
0.299
0.182
0.165
Own earn%
20.64
(43.47)
(11.32)
Sh yield%
58.90
33.57
34.53
Owners
Insiders/Inst%
2.78
43.59
Short interest%
1.07
SBC / revenue%
4.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
26–35
$1 testx
0.0
Incr. ROIC%
2